Our finding that individuals in whom intrinsically higher levels of FGFR2 are expressed in their skin fibroblasts also have higher levels of FGF10 suggests that the increased breast cancer risk might be due to a stronger paracrine effect between stromal and tumor cells involving FGF10 signaling. The gene discussed is FGF10; the disease is breast cancer.